Is Foundayo the new weight-loss pill from Eli Lilly?
What Foundayo (orforglipron) is and when it was authorised in the UK.
Foundayo is the brand name for orforglipron, a once-daily oral GLP-1 medicine from Eli Lilly. The MHRA authorised it in the UK on 10 August 2026 for weight management and type 2 diabetes. The UK was the first country in Europe to authorise it.
This is general information about prescription medicines, not advice or a recommendation to use them. Speak to your prescriber or pharmacist about your own treatment.
Sources we checked
- Foundayo: Summary of Product Characteristics (electronic Medicines Compendium (UK))
This article is general information, not medical advice. Speak to a doctor, pharmacist or other qualified clinician about your own health, especially before starting a supplement or if symptoms are new, severe or worrying.
Got a question about this, or a claim you want checked? Ask us.
Read next
How to check an online pharmacy is legitimate before buying weight-loss medication
Fake and unregulated sellers of weight-loss jabs are common. Here's how to check a pharmacy or clinic in the UK, US and elsewhere, in under five minutes.